NCT06582485: A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 200 planned
- Started
- Sep 2025
- Primary completion
- Dec 2026
- Arms
- Active treatment iCM012 solution 2 mg/mL
- Results
- None posted
- 3 Sep 2024: Trial registered